Bausch Health Companies logo

Bausch Health Companies

BHC | NYSE
Chart Builder DCF Calculator
$8.42
+$0.07 (+0.90%)
At close: Nov 16, 2026, 4:00 PM ET
$8.43
+$0.01 (+0.09%)
After-hours: Nov 16, 2026, 5:15 PM ET
+0.90%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
50.9
Fundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #264/1021 (Top 26%)

Key Statistics

Market Data

Market Cap $3.15B
1D Range
8.34 8.57
52W Range
4.43 8.91

Valuation (TTM)

PE -3.71
PB -2.37
EV/EBITDA 8.95

Valuation (NTM)

Forward PE 1.63
Forward PEG -0.12
Price Target $8.50
Loading financial charts...

Profile

Bausch Health Companies Inc., together with its associated entities, is engaged in the development, manufacturing, and commercialization of a diverse portfolio of pharmaceutical products, medical devi...

Sector Healthcare
Employees 20,300
IPO Date Mar 29, 1994
Fiscal Year January - December

Latest News

Here's Why Bausch Health (BHC) is a Strong Momentum Stock

4 days ago · zacks.com

Here's Why Bausch Health (BHC) is a Strong Momentum Stock
Bausch Health's Gastroenterology Business, Salix, to Present New Data on Cirrhosis Trends and Severe Alcohol-Associated Hepatitis at The Liver Meeting® 2026

11 days ago · prnewswire.com

Bausch Health's Gastroenterology Business, Salix, to Present New Data on Cirrhosis Trends and Severe Alcohol-Associated Hepatitis at The Liver Meeting® 2026
BHC Q3 Earnings Call Highlights Raised Outlook, Xifaxan Risks

13 days ago · zacks.com

BHC Q3 Earnings Call Highlights Raised Outlook, Xifaxan Risks
Is Bausch Health (BHC) Stock Outpacing Its Medical Peers This Year?

14 days ago · zacks.com

Is Bausch Health (BHC) Stock Outpacing Its Medical Peers This Year?
BHC Q3 Earnings Beat on Salix Growth, Stock Gains 9% as Outlook Rises

19 days ago · zacks.com

BHC Q3 Earnings Beat on Salix Growth, Stock Gains 9% as Outlook Rises
Bausch Health Companies Inc. (BHC) Q3 2026 Earnings Call Transcript

19 days ago · seekingalpha.com

Bausch Health Companies Inc. (BHC) Q3 2026 Earnings Call Transcript
Bausch (BHC) Reports Q3 Earnings: What Key Metrics Have to Say

19 days ago · zacks.com

Bausch (BHC) Reports Q3 Earnings: What Key Metrics Have to Say
Bausch Health (BHC) Surpasses Q3 Earnings and Revenue Estimates

19 days ago · zacks.com

Bausch Health (BHC) Surpasses Q3 Earnings and Revenue Estimates
What Bausch Health Cos (BHC) Said on Its Q3 Earnings Call

19 days ago · marketbeat.com

What Bausch Health Cos (BHC) Said on Its Q3 Earnings Call
Bausch Health Announces Full Redemption of 8.500% Senior Notes Due 2027

19 days ago · prnewswire.com

Bausch Health Announces Full Redemption of 8.500% Senior Notes Due 2027

Earnings

Latest Earnings
Oct 28, 2026
EPS
$1.77
Beat +41.60%
REV
$2.89B
Beat +5.96%
Next Earnings
Feb 17, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
4
Consensus
Hold
Price Target
$8.50
Upside
+0.95%
Buy (0)
Hold (4)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.